Byol Combi 5 mg/2,5 mg tvrde kapsule
| Name | Byol Combi 5 mg/2,5 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-495084169 |
| Active Substance | ramipril bisoprololfumarat |
| Composition | svaka tvrda kapsula sadrži 5 mg ramiprila i 2,5 mg bisoprololfumarata |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska
Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 11.05.2022 |
| MA Period of Validity | 11.05.2027 |
| Classification Number | UP/I-530-09/20-01/298 |
| Registration Number | 381-12-01/154-22-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BX05 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
